These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10639318)

  • 1. Cell growth regulatory and antiviral effects of the P69 isozyme of 2-5 (A) synthetase.
    Ghosh A; Sarkar SN; Sen GC
    Virology; 2000 Jan; 266(2):319-28. PubMed ID: 10639318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutive expression of a 2',5'-oligoadenylate synthetase cDNA results in increased antiviral activity and growth suppression.
    Rysiecki G; Gewert DR; Williams BR
    J Interferon Res; 1989 Dec; 9(6):649-57. PubMed ID: 2481699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A full-length murine 2-5A synthetase cDNA transfected in NIH-3T3 cells impairs EMCV but not VSV replication.
    Coccia EM; Romeo G; Nissim A; Marziali G; Albertini R; Affabris E; Battistini A; Fiorucci G; Orsatti R; Rossi GB
    Virology; 1990 Nov; 179(1):228-33. PubMed ID: 2171206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of both domains of the 69/71 kDa 2',5' oligoadenylate synthetase generates a catalytically active enzyme and mediates an anti-viral response.
    Marié I; Rebouillat D; Hovanessian AG
    Eur J Biochem; 1999 May; 262(1):155-65. PubMed ID: 10231377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional induction of the p69 isoform of 2',5'-oligoadenylate synthetase by interferon-beta and interferon-gamma involves three regulatory elements and interferon-stimulated gene factor 3.
    Floyd-Smith G; Wang Q; Sen GC
    Exp Cell Res; 1999 Jan; 246(1):138-47. PubMed ID: 9882523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzymatic characteristics of recombinant medium isozyme of 2'-5' oligoadenylate synthetase.
    Sarkar SN; Bandyopadhyay S; Ghosh A; Sen GC
    J Biol Chem; 1999 Jan; 274(3):1848-55. PubMed ID: 9880569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired antiviral response in human hepatoma cells.
    Keskinen P; Nyqvist M; Sareneva T; Pirhonen J; Melén K; Julkunen I
    Virology; 1999 Oct; 263(2):364-75. PubMed ID: 10544109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct antiviral roles for human 2',5'-oligoadenylate synthetase family members against dengue virus infection.
    Lin RJ; Yu HP; Chang BL; Tang WC; Liao CL; Lin YL
    J Immunol; 2009 Dec; 183(12):8035-43. PubMed ID: 19923450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of an antiviral state by interferon in the absence of elevated levels of 2,5-oligo(A) synthetase and eIF-2 kinase.
    Lewis JA
    Virology; 1988 Jan; 162(1):118-27. PubMed ID: 2447700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein synthesis-dependent and -independent induction of p69 2'-5'-oligoadenylate synthetase by interferon-alpha.
    Yu F; Floyd-Smith G
    Cytokine; 1999 Oct; 11(10):744-50. PubMed ID: 10525312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-induced guanylate binding protein-1 (GBP-1) mediates an antiviral effect against vesicular stomatitis virus and encephalomyocarditis virus.
    Anderson SL; Carton JM; Lou J; Xing L; Rubin BY
    Virology; 1999 Mar; 256(1):8-14. PubMed ID: 10087221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of intracellular interferon constitutively activates ISGF3 and confers resistance to EMC viral infection.
    Rutherford MN; Kumar A; Coulombe B; Skup D; Carver DH; Williams BR
    J Interferon Cytokine Res; 1996 Jul; 16(7):507-10. PubMed ID: 8836915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crisscross enzymatic reaction between the two molecules in the active dimeric P69 form of the 2'-5' oligodenylate synthetase.
    Sarkar SN; Pal S; Sen GC
    J Biol Chem; 2002 Nov; 277(47):44760-4. PubMed ID: 12223486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral activity of prostaglandin A on encephalomyocarditis virus-infected cells: a unique effect unrelated to interferon.
    Ankel H; Mittnacht S; Jacobsen H
    J Gen Virol; 1985 Nov; 66 ( Pt 11)():2355-64. PubMed ID: 2414395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A specific isozyme of 2'-5' oligoadenylate synthetase is a dual function proapoptotic protein of the Bcl-2 family.
    Ghosh A; Sarkar SN; Rowe TM; Sen GC
    J Biol Chem; 2001 Jul; 276(27):25447-55. PubMed ID: 11323417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulated expression of the interferon-induced protein kinase p68 (PKR) by vaccinia virus recombinants inhibits the replication of vesicular stomatitis virus but not that of poliovirus.
    Lee SB; Bablanian R; Esteban M
    J Interferon Cytokine Res; 1996 Dec; 16(12):1073-8. PubMed ID: 8974011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alpha interferon, antiviral proteins and their value in clinical medicine].
    Chieux V; Hober D; Chehadeh W; Wattré P
    Ann Biol Clin (Paris); 1999; 57(6):659-66. PubMed ID: 10572214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon action in human fibroblasts: induction of 2', 5'-oligoadenylate synthetase in the absence of detectable protein kinase activity.
    Holmes SL; Gupta SL
    Arch Virol; 1982; 72(1-2):137-42. PubMed ID: 6179503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production, purification, and characterization of recombinant 2', 5'-oligoadenylate synthetases.
    Sarkar SN; Sen GC
    Methods; 1998 Jul; 15(3):233-42. PubMed ID: 9735308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferons and antiviral activity.
    Jacobsen H
    Arzneimittelforschung; 1986 Mar; 36(3):512-6. PubMed ID: 2423095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.